Clinical Trial Update: Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining IMM 124-E for severe alcoholic hepatitis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• IMM 124-E (bovine colostrum)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Hepatitis, Alcoholic | Phase 2 | Status: COMPLETED | Results posted: 2020-01-27